Vis enkel innførsel

dc.contributor.authorBaumbusch, Lars O.en_US
dc.contributor.authorMyhre, Simenen_US
dc.contributor.authorLangerød, Anitaen_US
dc.contributor.authorBergamaschi, Annaen_US
dc.contributor.authorGeisler, Stephanieen_US
dc.contributor.authorLønning, Per Eysteinen_US
dc.contributor.authorDeppert, Wolfgangen_US
dc.contributor.authorDornreiter, Ireneen_US
dc.contributor.authorBørresen-Dale, Anne-Liseen_US
dc.date.accessioned2006-11-24T16:10:00Z
dc.date.available2006-11-24T16:10:00Z
dc.date.issued2006-10-20eng
dc.identifier.issn1476-4598
dc.identifier.urihttps://hdl.handle.net/1956/1963
dc.description.abstractBackground: The tumor suppressor gene p53 (TP53) controls numerous signaling pathways and is frequently mutated in human cancers. Novel p53 isoforms suggest alternative splicing as a regulatory feature of p53 activity. Results: In this study we have analyzed mRNA expression of both wild-type and mutated p53 and its respective Δp53 isoform in 88 tumor samples from breast cancer in relation to clinical parameters and molecular subgroups. Three-dimensional structure differences for the novel internally deleted p53 isoform Δp53 have been predicted. We confirmed the expression of Δp53 mRNA in tumors using quantitative real-time PCR technique. The mRNA expression levels of the two isoforms were strongly correlated in both wild-type and p53-mutated tumors, with the level of the Δp53 isoform being approximately 1/3 of that of the full-length p53 mRNA. Patients expressing mutated full-length p53 and non-mutated (wild-type) Δp53, "mutational hybrids", showed a slightly higher frequency of patients with distant metastasis at time of diagnosis compared to other patients with p53 mutations, but otherwise did not differ significantly in any other clinical parameter. Interestingly, the p53 wild-type tumors showed a wide range of mRNA expression of both p53 isoforms. Tumors with mRNA expression levels in the upper or lower quartile were significantly associated with grade and molecular subtypes. In tumors with missense or in frame mutations the mRNA expression levels of both isoforms were significantly elevated, and in tumors with nonsense, frame shift or splice mutations the mRNA levels were significantly reduced compared to those expressing wild-type p53. Conclusion: Expression of p53 is accompanied by the functionally different isoform Δp53 at the mRNA level in cell lines and human breast tumors. Investigations of "mutational hybrid" patients highlighted that wild-type Δp53 does not compensates for mutated p53, but rather may be associated with a worse prognosis. In tumors, both isoforms show strong correlations in different mutation-dependent mRNA expression patterns.en_US
dc.format.extent590639 byteseng
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherBioMed Centraleng
dc.relation.ispartofseriesMolecular Cancer 5(47)en
dc.titleExpression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parametersen_US
dc.typePeer reviewed
dc.typeJournal article
dc.identifier.doihttps://doi.org/10.1186/1476-4598-5-47
dc.identifier.cristin375875
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762nob


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel